Pathogens and Disease · 2017 · 12 citations · 50 references
Life SciencesImmunologyMicrobiologyHost-pathogen InteractionsImmunology Of Infectious DiseasesInnate ImmunityInflammatory SignalingInnate Immune ReceptorsInnate Immune RecognitionInnate Immune ResponseNeutrophil BiologyPhagocyte BiologyAntibacterial Innate SignalingCell Surface Recognition ReceptorsFc ReceptorsInflammatory Response To Bacterial InfectionNeutrophil Responses To BacteriaPhagocyte ActivationPhagocyte Recognition MechanismsPhagocytosis Of Bacteria
Here, we describe the application of an 'artificial opsonin' to stimulate the innate immune response against Gram-positive bacteria. The artificial opsonin comprises a poly(L-lysine)-graft-poly(ethylene glycol) backbone displaying multiple copies of vancomycin and human IgG-Fc. The vancomycin targets bacteria by recognizing d-Ala-d-Ala-terminated peptides present in the bacterial cell wall. The human IgG-Fc antibody fragments serve as phagocyte recognition moieties that recognize the Fcγ cell surface receptors expressed by professional human phagocytes. Staphylococcus epidermidis RP62A, a biofilm-forming, methicillin-resistant strain, was utilized to investigate the effects of opsonization on phagocytosis, oxidative burst and IL-8 chemokine production by human neutrophils. Results show that opsonization of S. epidermidis RP62A with the artificial opsonin resulted in an ∼2-fold increase in neutrophil phagocytosis. Analysis of the cell supernatant found a 2- to 3-fold increase in neutrophil IL-8 secretion. The neutrophil oxidative burst was investigated using the oxidation-sensitive fluorophore dihydrorhodamine-123. Bacterial opsonization resulted in a 20% increase in fluorescence intensity, indicating a significant increase in the production of reactive oxygen species by the neutrophils. These studies suggest that artificial opsonins may be a novel immunostimulation therapeutic strategy to control infections caused by Gram-positive bacteria, particularly those that are known to be immune evasive and/or antibiotic resistant.
50
Howard Ceri, Merle S. Olson, Carol A. Stremick et al. · Journal of Clinical Microbiology · 1999 · 2.1K citations · Full text
The 3.2-Å crystal structure of the human IgG1 Fc fragment–FcγRIII complex
Peter Sondermann, Robert Huber, Vaughan Oosthuizen et al. · Nature · 2000 · 715 citations
Life Sciences, Biology, Immunology +11
Choice Reviews Online · 2008 · 651 citations